- Home
- BTAI vs SCKT Comparison
BTAI vs SCKT Comparison
Compare BTAI & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- SCKT
- Stock Information
- Founded
- BTAI 2017
- SCKT 1992
- Country
- BTAI United States
- SCKT United States
- Employees
- BTAI N/A
- SCKT N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- SCKT Computer Manufacturing
- Sector
- BTAI Health Care
- SCKT Technology
- Exchange
- BTAI Nasdaq
- SCKT Nasdaq
- Market Cap
- BTAI 8.3M
- SCKT 9.3M
- IPO Year
- BTAI 2018
- SCKT 1995
- Fundamental
- Price
- BTAI $1.93
- SCKT $1.14
- Analyst Decision
- BTAI Buy
- SCKT
- Analyst Count
- BTAI 5
- SCKT 0
- Target Price
- BTAI $34.60
- SCKT N/A
- AVG Volume (30 Days)
- BTAI 289.2K
- SCKT 15.8K
- Earning Date
- BTAI 08-05-2025
- SCKT 07-30-2025
- Dividend Yield
- BTAI N/A
- SCKT N/A
- EPS Growth
- BTAI N/A
- SCKT N/A
- EPS
- BTAI N/A
- SCKT N/A
- Revenue
- BTAI $1,852,000.00
- SCKT $17,750,643.00
- Revenue This Year
- BTAI $5.03
- SCKT $8.62
- Revenue Next Year
- BTAI $291.01
- SCKT N/A
- P/E Ratio
- BTAI N/A
- SCKT N/A
- Revenue Growth
- BTAI 5.47
- SCKT 0.29
- 52 Week Low
- BTAI $1.17
- SCKT $0.91
- 52 Week High
- BTAI $21.92
- SCKT $1.72
- Technical
- Relative Strength Index (RSI)
- BTAI 56.97
- SCKT 49.42
- Support Level
- BTAI $1.69
- SCKT $1.13
- Resistance Level
- BTAI $2.08
- SCKT $1.19
- Average True Range (ATR)
- BTAI 0.20
- SCKT 0.05
- MACD
- BTAI 0.02
- SCKT 0.00
- Stochastic Oscillator
- BTAI 61.84
- SCKT 42.86
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.